Mastoiditis secondary to mycobacterium abscessus imaged with gallium-67 scintigraphy

Department of Biomedical Imaging, University of Malaya, Kuala Lumpur, Malaysia

Abstract

Atypical mycobacterium is rarely seen as a cause of chronic mastoiditis but has been increasingly recognized over the past few years. Mycobacterium abscessus is the most pathogenic and chemotherapy-resistant, rapid-growing mycobacterium of all the four groups. This paper presents a case of a 57-year-old woman who had chronic mastoiditis with recurrent exacerbations. The initial computed tomography (CT) findings showed the presence of an inflammatory process and she was treated with the appropriate antibiotics. The patient subsequently underwent a tissue biopsy when she presented with another exacerbation. At this time, the CT scan did not identify the ongoing exacerbation, but the Gallium-67 scintigraphy did. © 2008 Biomedical Imaging and Intervention Journal. All rights reserved.

Introduction

Atypical mycobacterium is a rare entity implicated in de novo mastoiditis. There are very few reported cases especially in the South-East Asian region. Various strains of atypical mycobacterium have been known to cause disease in human beings, since their isolation in the 1920s. Of the four groups of atypical mycobacterium, the group IV rapid growers (Mycobacterium abscessus and Mycobacterium fortuitum) are the ones which are recognized as human pathogens [1].

This paper presents a case of a 57-year-old woman who had chronic recurring mastoiditis and discusses the computed tomography (CT) findings and the use of the Gallium-67 scintigraphy in this condition.

Case Report

A 57-year-old woman, presented to the ENT clinic with gradual loss of hearing and bilateral ear discharge. She also noticed that pieces of bone were extruding from her left ear. She had been suffering from chronic bilateral ear discharge since her early teenage years. The physical examination done by the otorhinolaryngologist had shown some ear discharge, but there was no evidence of abscess formation, nor was there any facial nerve palsy noted. A presumptive diagnosis of bilateral chronic suppurative otitis media was made. Her blood investigations were essentially normal apart from the normocytic normochromic anemia. Ear swabs from the external auditory canal were sent for microbiological analysis (culture and sensitivity) for pathogens, including Mycobacterium tuberculosis.

A CT scan of the temporal bones revealed sclerosis of both mastoid air cells with presence of soft tissue, bony erosion and bony fragments within the external auditory canal (Figure 1 & 2). She was started on treatment with oral co-trimoxazole because the initial clinical diagnosis prior to the imaging studies was chronic suppurative otitis media. Her ear discharge resolved and her hearing improved. The cultures were negative for pathogens, including tuberculosis. After completing two months of oral antibiotics, she began to notice discharge from her right ear. Due to the recurrent nature of the infection, a tissue biopsy of the ear was performed and sent for culture and sensitivity screening.

The tissue biopsy of the affected ear isolated a rapidly growing atypical mycobacterium – Mycobacterium abscessus which was resistant to co-trimoxazole (Bactrim) but sensitive to imipenem (intravenous beta-lactam antibiotics), clarithromycin and azithromycin. She was commenced on imipenem and clarithromycin. Intravenous amikacin was administered initially for synergistic reasons but the patient was unable to tolerate amikacin and it was withheld. This dual antibiotic regime was continued for a total of 40 days without any complications.

A repeat CT scan of the temporal bone showed consolidation of the previously inflamed bony lesions but was unable to give any information on the activity of infection. A Gallium-67 (⁶⁷Ga) scan was performed and showed raised ⁶⁷Ga uptake in the right petromastoid region (Figures 3 and 4). The left petromastoid region showed near normal, but slightly increased radiotracer uptake. This indicated the presence of active infection and the need to continue treatment.       

Upon completing the initial regime of antibiotics, she was started on oral doxycycline 100mg bd, clarithromycin 500mg bd and moxifloxacin 400mg bd for life. She has been on regular follow up since then and has been well.

Discussion

Mycobacteria are slow-growing aerobic, immobile bacilli that have been identified by the property of acid-fastness. Atypical or non-tuberculous Mycobacteria have been distinguished from the Mycobacterium tuberculosis complex and classified into four groups by Runyon based on the speed of growth, morphology and biochemical reactions [1]. Atypical mycobacteria are known to cause other clinical syndromes such as lymphadenitis in children, lung and cutaneous infections in adults, and disseminated infections in immunosuppressed patients. They are isolated and transmitted through contaminated water. Geographically, outbreaks of atypical mycobacterial infection have been reported especially in the Rocky Mountain territories of North America [1, 2].

Mycobacterium abscessus (previously known as M. chelonae, subspecies abscessus) is a rare cause of chronic mastoiditis, as less than 10 cases have been reported so far. According to Redaelli de Zinis et al, there were only seven cases of otitis media caused by Mycobacterium abscessus from 1976 to 2001 [2]. Mycobacterium abscessus is the most pathogenic and chemotherapy-resistant rapid-growing mycobacteria commonly associated with penetrating trauma, surgery and the presence of foreign bodies. It is also one of the mycobacteria that are most often isolated from cystic fibrosis patients [3].

Infection caused by atypical mycobacterium in the petro-mastoid region causes significant diagnostic and prognostic confusion. There are no definite CT scan appearances to convince the clinician of the presence of residual infection. At this juncture, it is of value to follow up such cases with Gallium-67 (⁶⁷Ga ) scintigraphy [4]. From a clinical standpoint, objective evidence of resolution of infection will help to guide the management of these patients. It will allow the discontinuation of prolonged antibiotic therapy, which may be expensive and potentially toxic.

The mechanism of ⁶⁷Ga localization in inflamed and infected tissue is believed to occur through three main processes. ⁶⁷Ga is carried bound to plasma transferrins to sites of inflammation and infection. It is also retained within the intracellular lactoferrin of leucocytes which will then migrate and accumulate at infection sites. Finally, ⁶⁷Ga itself may be bound to the siderophores produced by pathogenic organisms localized at infection sites [4]. It localizes very early and in relatively high concentrations in the event of inflammation of the bony tissue. This makes it the preferred technique for assessing resolution of infection and to diagnose subclinical mastoiditis [4, 5]. The improvement or return to normal of ⁶⁷Ga uptake at infection sites correlates well with the clinical inactivity of the infection.

⁶⁷Ga-citrate also accumulates in sites of active bone remodeling but the intensity of uptake is relatively higher in the presence of infection and it is less likely to persist following resolution of infection. Thus used in combination, technetium-based agents and ⁶⁷Ga would be useful in both diagnosing as well as in the follow-up of these cases [6].

In a study done by Strashun AM and colleagues in 1984, it was found that clinically confirmed cases of otitis media were often radiographically negative early in the course of the disease. However, radionuclide scintigraphy with technetium and gallium radiopharmaceuticals, have been demonstrated to be a more sensitive imaging modality [4]. Although CT is excellent for the localization and follow up of progression of soft tissue in the petromastoid region, it cannot be used accurately in the follow up of regression or inactivity of infection in this region [5]. This is due to the slow process of re-ossification in the skull bone.

CT is not significantly more sensitive (33%) than routine radiographic techniques. Presumably this failure of early detection is due to the clinical situation in which the inflammatory response, both soft tissue and bone, causes severe and persistent ear pain that forces the patient to seek attention only at the point in the disease where 30-50% of trabecular bone has been destroyed.

Additionally, the regional anatomy does not provide the same advantages of earlier soft-tissue changes including swelling and displacement of contiguous fat lines, swelling and obliteration of lucent planes between muscles and subcutaneous edema, relied upon radiographically to suggest the possibility of early long-bone osteomyelitis [4].

In this patient, the Mycobacterium abscessus isolated was resistant to co-trimoxazole. It is important to note that the patient was on a single therapy regimen for two weeks on this particular antibiotic. This was because the initial working diagnosis was chronic suppurative otitis media and co-trimoxazole is one of the antibiotics utilized in this condition. Furthermore, the culture and sensitivity of the ear swabs were not known at the initiation of therapy. Nevertheless, the initial discharge had cleared with clinical improvement after two months of treatment. It is likely that the Mycobacterium abscessus pathogen was initially sensitive to co-trimoxazole, however, as it was only a mono-therapy, the pathogen gradually developed resistance and the patient became symptomatic again [7].

Atypical rapidly-growing mycobacteria are resistant to conventional antimycobacterial therapy, except aminoglycosides. New drugs such as clarithromycin and erythromycin derivatives, with slightly greater activity than the parent compound and fewer side effects than erythromycin, have proven to be effective in treating M. chelonei infections [8]. The role of life-long antibiotic therapy is still under trial and is used at a few centres worldwide.

[View this Figure]

Figure 1 CT scan of temporal bone - Coronal reconstruction image showing soft tissue filling up the external auditory canal and the middle ear (long white arrows). There are also bony fragments seen (short black arrows).

[View this Figure]

Figure 2 CT of temporal bone - axial image, in bone window showing soft tissue filling up the external auditory canal and the middle ear (long white arrows). The bony fragments are clearly seen in this window. (short black arrows).

[View this Figure]

Figure 3 67Ga scintigraphy showing uptake in the right mastoid region. (black arrow).

[View this Figure]

Figure 4 SPECT 67Ga scintigraphy images showing significantly increased uptake in the right petromastoid region. (black arrow).

References

1. Heitzman ER, Bornhurst RA, Russell JP. Disease due to anonymous mycobacteria. Potential for specific diagnosis. Am J Roentgenology, Radium Therapy, and Nuclear Medicine 1968; 103(3):533-9.  
   
2. Redaelli de Zinis LO, Tironi A, Nassif N et al. Temporal bone infection caused by atypical mycobacterium: case report and review of the literature. Otol Neurotol 2003; 24(6):843-9.   [Medline]
   
3. Petrini B. Mycobacterium abscessus: an emerging rapid-growing potential pathogen. APMIS 2006; 114(5):319-28.   [Medline] [CrossRef]
   
4. Strashun AM, Nejatheim M, Goldsmith SJ. Malignant external otitis: early scintigraphic detection. Radiology 1984; 150(2):541-5.   [Medline]
   
5. Mendelson DS, Som PM, Mendelson MH et al. Malignant external otitis: the role of computed tomography and radionuclides in evaluation. Radiology 1983; 149(3):745-9.   [Medline]
   
6. Mettler FA, Milton JG. Essentials of Nuclear Medicine Imaging. 5th edition. Philadelphia: Saunders-Elsevier, 2006: 341-2.  
   
7. Woods GL, Bergmann JS, Witebsky FG et al. Multisite reproducibility of Etest for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum. J Clin Microbiol 2000; 38(2):656-61.   [Medline]
   
8. McFarland EJ, Kuritzkes DR. Clinical features and treatment of infection due to mycobacterium fortuitum/chelonae complex. Curr Clin Top Infect Dis 1993; 13:188-202.   [Medline]
   

Leave a comment

Full name *
Email *
Affiliation
Please select ... Abkhazia Afghanistan Aland Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Ascension Ashmore and Cartier Islands Australia Australian Antarctic Territory Austria Azerbaijan Bahamas, The Bahrain Baker Island Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Bouvet Island Brazil British Antarctic Territory British Indian Ocean Territory British Sovereign Base Areas British Virgin Islands Brunei Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China, People's Republic of China, Republic of (Taiwan) Christmas Island Clipperton Island Cocos (Keeling) Islands Colombia Comoros Congo, Democratic Republic of the Congo, Republic of the Cook Islands Coral Sea Islands Costa Rica Cote d'Ivoire (Ivory Coast) Croatia Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Islas Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern and Antarctic Lands Gabon Gambia, The Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Honduras Hong Kong Howland Island Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jarvis Island Jersey Johnston Atoll Jordan Kazakhstan Kenya Kingman Reef Kiribati Korea, Democratic People's Republic of Korea, Republic of Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Midway Islands Moldova Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar (Burma) Nagorno-Karabakh Namibia Nauru Navassa Island Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Cyprus Northern Mariana Islands Norway Oman Pakistan Palau Palestinian Territories Palmyra Atoll Panama Papua New Guinea Paraguay Peru Peter I Island Philippines Pitcairn Islands Poland Portugal Pridnestrovie (Transnistria) Puerto Rico Qatar Queen Maud Land Reunion Romania Ross Dependency Russia Rwanda S. Georgia and the S. Sandwich Islands Saint Barthelemy Saint Helena Saint Kitts and Nevis Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia Somaliland South Africa South Ossetia Spain Sri Lanka Sudan Suriname Svalbard Swaziland Sweden Switzerland Syria Tajikistan Tanzania Thailand Timor-Leste (East Timor) Togo Tokelau Tonga Trinidad and Tobago Tristan da Cunha Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu U.S. Virgin Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Wake Island Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe Country *

Password *